Oocyte donation in donors with levonorgestrel intrauterine device: a good match?


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 25 02 2019
revised: 24 04 2019
accepted: 31 05 2019
pubmed: 1 8 2019
medline: 21 8 2020
entrez: 1 8 2019
Statut: ppublish

Résumé

Does the levonorgestrel-releasing intrauterine device (LNG-IUD) influence cumulative live birth rate (CLBR) in oocyte donor cycles? Retrospective cohort study based on prospectively collected data from 1 May 2009 to 31 December 2017, without attrition, consisting of 491 consecutive cycles of vitrified oocyte donation, none lost to follow-up (unique donor-recipient pairs). All donors underwent ovarian stimulation using gonadotrophin releasing hormone (GnRH) antagonist co-treatment and GnRH agonist trigger. CLBR was chosen as primary outcome measure. In total, 103 (21.0%) cycles were carried out in donors carrying a LNG-IUD. In 388 (79.0%) cycles, no LNG-IUD was present. After confounder-adjustment, the use of an LNG-IUD did not have a statistically significant influence on CLBR. The LNG-IUD does not negatively affect CLBR.

Identifiants

pubmed: 31362915
pii: S1472-6483(19)30586-3
doi: 10.1016/j.rbmo.2019.05.022
pii:
doi:

Substances chimiques

Contraceptive Agents, Female 0
Levonorgestrel 5W7SIA7YZW

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

641-647

Informations de copyright

Copyright © 2019 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Ana Galvão (A)

Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium; Department of Obstetrics and Gynaecology, Centro Materno Infantil do Norte, Centro Hospitalar do Porto, Largo da Maternidade de Júlio Dinis 30, 4050-651 Porto, Portugal.

Gunes Karakus (G)

Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium; Department of Obstetrics and Gynaecology, Santarem Hospital, R. Zeferino Silva, Santarém, Portugal.

Annalisa Racca (A)

Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium.

Samuel Santos-Ribeiro (S)

Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium; IVI-RMA Lisboa, Avenida Infante Dom Henrique 333 H 1-9, Lisbon 1800-282, Portugal.

Neelke De Munck (N)

Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium.

Panagiotis Drakopoulos (P)

Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium.

Michel De Vos (M)

Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium.

Greta Verheyen (G)

Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium.

Herman Tournaye (H)

Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium.

Christophe Blockeel (C)

Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium; University of Zagreb-School of Medicine, Department of Obstetrics and Gynaecology Zagreb, Croatia. Electronic address: christophe.blockeel@uzbrussel.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH